TY - JOUR
T1 - Rhabdomyosarcoma with heterologous cartilage of the uterine cervix
T2 - A clinicopathologic and immunohistochemical study of an aggressive neoplasm in a young female
AU - Perrone, Theresa
AU - Carson, Linda F.
AU - Dehner, Louis P.
PY - 1990
Y1 - 1990
N2 - This report concerns a 20‐year‐old female who had a F.I.G.O. stage I rhabdomyosarcoma (sarcoma botryoides) of the cervix with a predominant embryonal pattern and heterologous cartilage that pursued an aggressive course despite surgery and chemotherapy. The patient had a pelvic recurrence, developed pulmonary metastases 15 months after diagnosis, and died 6 months later. Despite some previously published favorable prognostic assessments about this unique variant of cervical rhabdomyosarcoma, our limited experience would interject a note of caution, especially in the presence of a focal alveolar pattern and invasion of lymphatics in the cervix.
AB - This report concerns a 20‐year‐old female who had a F.I.G.O. stage I rhabdomyosarcoma (sarcoma botryoides) of the cervix with a predominant embryonal pattern and heterologous cartilage that pursued an aggressive course despite surgery and chemotherapy. The patient had a pelvic recurrence, developed pulmonary metastases 15 months after diagnosis, and died 6 months later. Despite some previously published favorable prognostic assessments about this unique variant of cervical rhabdomyosarcoma, our limited experience would interject a note of caution, especially in the presence of a focal alveolar pattern and invasion of lymphatics in the cervix.
KW - alveolar rhabdomyosarcoma
KW - embryonal rhabdomyosarcoma
KW - sarcoma botryoides
KW - uterine cervix neoplasms
UR - http://www.scopus.com/inward/record.url?scp=0025141767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025141767&partnerID=8YFLogxK
U2 - 10.1002/mpo.2950180116
DO - 10.1002/mpo.2950180116
M3 - Article
C2 - 2294394
AN - SCOPUS:0025141767
SN - 1545-5009
VL - 18
SP - 72
EP - 76
JO - Medical and Pediatric Oncology
JF - Medical and Pediatric Oncology
IS - 1
ER -